[go: up one dir, main page]

Endometrial Neoplasms

"Endometrial Neoplasms" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

expand / collapse MeSH information
Tumors or cancer of ENDOMETRIUM, the mucous lining of the UTERUS. These neoplasms can be benign or malignant. Their classification and grading are based on the various cell types and the percent of undifferentiated cells.


expand / collapse Publications
This graph shows the total number of publications written about "Endometrial Neoplasms" by people in this website by year, and whether "Endometrial Neoplasms" was a major or minor topic of these publications.
Below are the most recent publications written about "Endometrial Neoplasms" by people in Profiles.
  1. Associated Trends in Obesity and Endometrioid Endometrial Cancer in the United States. Obstet Gynecol. 2025 Mar 01; 145(3):e107-e116.
    View in: PubMed
  2. Understanding risk factors for endometrial cancer in young women. J Natl Cancer Inst. 2025 Jan 01; 117(1):76-88.
    View in: PubMed
  3. Characterization of gastric/gastrointestinal-like immunophenotypes in endometrial endometrioid adenocarcinomas, including endometrioid adenocarcinomas with mucinous differentiation. Hum Pathol. 2024 Dec; 154:105707.
    View in: PubMed
  4. History of Infertility and Risk of Endometrial Cancer in the Women's Health Initiative. Cancer Epidemiol Biomarkers Prev. 2024 Dec 02; 33(12):1683-1689.
    View in: PubMed
  5. Cervicovaginal lavages uncover growth factors as key biomarkers for early diagnosis and prognosis of endometrial cancer. Mol Biomed. 2024 11 08; 5(1):55.
    View in: PubMed
  6. Early-Life Factors and Early-Onset Endometrial Cancer Risk in the UK Biobank. JAMA Netw Open. 2024 Oct 01; 7(10):e2440181.
    View in: PubMed
  7. ENGOT-en11/GOG-3053/KEYNOTE-B21: a randomised, double-blind, phase III study of pembrolizumab or placebo plus adjuvant chemotherapy with or without radiotherapy in patients with newly diagnosed, high-risk endometrial cancer. Ann Oncol. 2024 Nov; 35(11):968-980.
    View in: PubMed
  8. Preclinical evaluation of avutometinib and defactinib in high-grade endometrioid endometrial cancer. Cancer Med. 2024 Sep; 13(17):e70210.
    View in: PubMed
  9. Weight-loss therapy in patients with obesity with endometrial intraepithelial neoplasia and uterine cancer. Gynecol Oncol. 2024 Nov; 190:78-83.
    View in: PubMed
  10. Incidence of endometrial cancer in BRCA mutation carriers. Gynecol Oncol. 2024 Oct; 189:148-155.
    View in: PubMed